ZY

ZHENGYE BIOTECHNOLOGY HLDG L

ZYBT·G989MS101·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic

ZYBT (ZHENGYE BIOTECHNOLOGY HLDG L) is held by 5 institutional investors as of Q1 2026. Largest holders: XTX Topco Ltd ($41,268), GEODE CAPITAL MANAGEMENT, LLC ($27,172), UBS Group AG ($7,514). Net institutional sentiment: Bearish.

5
Holders
Avg rating(1 Elite)
$77,198
Total Value
14% (8)
Fund Consensus
1 buying - 6 selling

No verdict yet — fewer than 2 funds hold ZYBT.

13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
44,146(-25.5%)$41,2680.0%-55.39%
0
Unchanged
29,068$27,1720.0%-88.20%
0
Decreased
8,036(-11.8%)$7,5140.0%-79.07%
0
Increased
1,230(+221.2%)$1,0000.0%-11.57%
12
Decreased
261(-83.8%)$2440.0%-88.15%
0
Exited
0(-100.0%)$35,1620.0%-49.84%
0
Exited
0(-100.0%)$5260.0%-31.86%
0
Exited
0(-100.0%)$39,8910.0%-88.35%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used